Veterinary Oncology Services, Inc. is a fully integrated service provider of personalized cancer vaccines for companion animals. Customization of the technology for each specific patient has been made possible by carefully honing the process so that it is rapid, efficient and cost-effective. The Veterinary Oncology Services process has been tested in laboratory mice and in companion animals in clinical settings. To date, the personalized vaccine has been provided to veterinarians for the treatment of 45 different types of cancer in over 120 breeds of dogs, cats, and horses. Veterinary Oncology Services is headquartered in Tampa, FL and provides services to veterinarians and their clients throughout the US.
This product is for experimental use only. Its safety and efficacy have not been established. Product may cause an injection site reaction.
Our autologous prescription product is a personalized cancer vaccine is now available throughout the US for the treatment of companion animals. This immunotherapy is created for each pet using their own cancer cells in our state-of-the-art manufacturing facility by our experienced scientists.
The vaccine primes and educates the immune system to attack tumor cells specifically, throughout the body.
Our cancer vaccine is a multi-indication cancer immunotherapy developed by Morphogenesis and offered as a service to veterinarians by Veterinary Oncology Services, Inc. The autologous prescription product is a personalized autologous cancer vaccine, i.e. it is made from each patient’s own cells. The cells to make the vaccine are most often collected at the time of surgery when the tumor mass is removed or is debulked.
Mechanism of Action